BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 3139283)

  • 1. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.
    Verma AK; Johnson JA; Gould MN; Tanner MA
    Cancer Res; 1988 Oct; 48(20):5754-8. PubMed ID: 3139283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
    el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
    Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets.
    Abou-el-Ela SH; Prasse KW; Farrell RL; Carroll RW; Wade AE; Bunce OR
    Cancer Res; 1989 Mar; 49(6):1434-40. PubMed ID: 2538226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
    VanderPloeg LC; Wolfrom DM; Welsch CW
    Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of sesamin against 7,12-dimethylbenz[a]-anthracene induced rat mammary carcinogenesis.
    Hirose N; Doi F; Ueki T; Akazawa K; Chijiiwa K; Sugano M; Akimoto K; Shimizu S; Yamada H
    Anticancer Res; 1992; 12(4):1259-65. PubMed ID: 1386971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of caffeine consumption on 7,12-dimethylbenz(a)anthracene-induced mammary gland tumorigenesis in female rats fed a chemically defined diet containing standard and high levels of unsaturated fat.
    Welsch CW; DeHoog JV
    Cancer Res; 1988 Apr; 48(8):2074-7. PubMed ID: 3127045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
    Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
    Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats.
    Hakkak R; Korourian S; Shelnutt SR; Lensing S; Ronis MJ; Badger TM
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):113-7. PubMed ID: 10667471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term feeding of sodium selenite on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the rat.
    Thompson HJ; Meeker LD; Becci PJ; Kokoska S
    Cancer Res; 1982 Dec; 42(12):4954-8. PubMed ID: 6814747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of n-3 and n-6 fatty acids on 7,12 dimethylbenz (a) anthracene-induced mammary tumorigenesis.
    Karmali RA; Donner A; Gobel S; Shimamura T
    Anticancer Res; 1989; 9(4):1161-7. PubMed ID: 2510582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by dietary selenite.
    Liu JZ; Gilbert K; Parker HM; Haschek WM; Milner JA
    Cancer Res; 1991 Sep; 51(17):4613-7. PubMed ID: 1908350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis.
    Koo KL; Tejwani GA; Abou-Issa H
    Anticancer Res; 1996; 16(4A):1893-8. PubMed ID: 8712718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting effects of high-fat corn oil and high-fat mixed lipid diets on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in F344 rats.
    Kuno T; Hirose Y; Yamada Y; Yoshida K; Qiao Z; Katayama M; Sakata K; Hara A; Sugie S; Mori H
    Oncol Rep; 2003; 10(3):699-703. PubMed ID: 12684646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of moderate vitamin A supplementation and lack of dietary vitamin A on the development of mammary tumors in female rats treated with low carcinogenic dose levels of 7,12-dimethylbenz(a)anthracene.
    Zile MH; Cullum ME; Roltsch IA; DeHoog JV; Welsch CW
    Cancer Res; 1986 Jul; 46(7):3495-503. PubMed ID: 3085923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
    Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
    Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dietary medium-chain triglycerides on the development of N-methylnitrosourea-induced rat mammary tumors.
    Cohen LA; Thompson DO; Maeura Y; Weisburger JH
    Cancer Res; 1984 Nov; 44(11):5023-8. PubMed ID: 6488161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
    Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.